Aortitis in giant cell arteritis and its complications;Aortite et complications aortiques de l'artérite à cellules géantes (maladie de Horton)

Revue de Medecine Interne

Volumn 34, Issue 7, 2013, Pages 412-420

  Espitia, O ^a   Agard, C ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Aortic aneurysm; Aortitis; Giant cell arteritis; Imaging studies; Positron emission tomography

Indexed keywords

ABDOMINAL AORTA; AORTA ANEURYSM; AORTA DISSECTION; AORTA RUPTURE; AORTITIS; ARTERITIS; ASCENDING AORTA; BLOOD VESSEL WALL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; RELAPSE; SHORT SURVEY;

AORTITIS; DIAGNOSTIC IMAGING; GIANT CELL ARTERITIS; HUMANS; PREVALENCE; PROGNOSIS;

EID: 84879605201     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.02.026     Document Type: Short Survey

References (106)

1. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., De Groot K., Gross W., et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009, 68:318-323.
2. Salvarani C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002, 347:261-271.
3. Baldursson O., Steinsson K., Björnsson J., Lie J.T. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994, 37:1007-1012.
4. Gilmour J. Giant-cell chronic arteritis. J Pathol 1941, 53:263-277.
5. Agard C., Barrier J.H., Dupas B., Ponge T., Mahr A., Fradet G., et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008, 59:670-676.
6. Narváez J., Narváez J.A., Nolla J.M., Sirvent E., Reina D., Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 2005, 44:479-483.
7. Bleeker-Rovers C.P., Bredie S.J.H., Van der Meer J.W.M., Corstens F.H.M., Oyen W.J.G. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003, 61:323-329.
8. Miller D.V., Isotalo P.A., Weyand C.M., Edwards W.D., Aubry M.C., Tazelaar H.D. Surgical pathology of noninfectious ascending aortitis: a study of 45cases with emphasis on an isolated variant. Am J Surg Pathol 2006, 30:1150-1158.
9. Ostberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand Suppl 1972, 533:135-159.
10. Petursdottir V., Nordborg E., Nordborg C. Atrophy of the aortic media in giant cell arteritis. APMIS 1996, 104:191-198.
11. Gornik H.L., Creager M.A. Aortitis. Circulation 2008, 117:3039-3051.
12. Kerr L.D., Chang Y.J., Spiera H., Fallon J.T. Occult active giant cell aortitis necessitating surgical repair. J Thorac Cardiovasc Surg 2000, 120:813-815.
13. Burke A.P., Tavora F., Narula N., Tomaszewski J.E., Virmani R. Aortitis and ascending aortic aneurysm: description of 52cases and proposal of a histologic classification. Hum Pathol 2008, 39:514-526.
14. Rojo-Leyva F., Ratliff N.B., Cosgrove D.M., Hoffman G.S. Study of 52patients with idiopathic aortitis from a cohort of 1,204surgical cases. Arthritis Rheum 2000, 43:901-907.
15. Liang K.P., Chowdhary V.R., Michet C.J., Miller D.V., Sundt T.M., Connolly H.M., et al. Noninfectious ascending aortitis: a case series of 64patients. J Rheumatol 2009, 36:2290-2297.
16. Pomerance A., Yacoub M.H., Gula G. The surgical pathology of thoracic aortic aneurysms. Histopathology 1977, 1:257-276.
17. Liu G., Shupak R., Chiu B.K. Aortic dissection in giant-cell arteritis. Semin Arthritis Rheum 1995, 25:160-171.
18. Weyand C.M., Goronzy J.J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003, 139:505-515.
19. Marie I., Proux A., Duhaut P., Primard E., Lahaxe L., Girszyn N., et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48patients. Medicine (Baltimore) 2009, 88:182-192.
20. Pacini D., Leone O., Turci S., Camurri N., Giunchi F., Martinelli G.N., et al. Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg 2008, 86:1518-1523.
21. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000, 108:246-249.
22. Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl 1972, 533:1-131.
23. Klein R.G., Hunder G.G., Stanson A.W., Sheps S.G. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975, 83:806-812.
24. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Suppl 1973, 237(Suppl. 237):1-59.
25. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 1971, 30:224-235.
26. Marie I., Lévesque H., Cailleux N., Héron F., Louvel J.P., Courtois H. [An unusual way of detecting Horton's disease: inflammatory abdominal aortitis]. J Mal Vasc 1998, 23:67-70.
27. Gonzalez-Gay M.A., Garcia-Porrua C., Piñeiro A., Pego-Reigosa R., Llorca J., Hunder G.G. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004, 83:335-341.
28. Evans J.M., Bowles C.A., Bjornsson J., Mullany C.J., Hunder G.G. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41cases. Arthritis Rheum 1994, 37:1539-1547.
29. Nuenninghoff D.M., Hunder G.G., Christianson T.J.H., McClelland R.L., Matteson E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50years. Arthritis Rheum 2003, 48:3522-3531.
30. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72cases with histopathologic documentation. Semin Arthritis Rheum 1995, 24:422-431.
31. Agard C., Ponge T., Fradet G., Baron O., Sagan C., Masseau A., et al. Giant cell arteritis presenting with aortic dissection: two cases and review of the literature. Scand J Rheumatol 2006, 35:233-236.
32. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995, 122:502-507.
33. Nuenninghoff D.M., Hunder G.G., Christianson T.J.H., McClelland R.L., Matteson E.L. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50years. Arthritis Rheum 2003, 48:3532-3537.
34. Prieto-González S., Arguis P., García-Martínez A., Espígol-Frigolé G., Tavera-Bahillo I., Butjosa M., et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40newly diagnosed patients using CT angiography. Ann Rheum Dis 2012, 71:1170-1176.
35. Weyand C.M., Goronzy J.J. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999, 42:844-853.
36. Agard C., Said L., Ponge T., Connault J., Masseau A., Pistorius M.A., et al. [Abdominal aortic involvement in active giant cell (temporal) arteritis: a study of 20patients by Doppler ultrasonography and computed tomographic angiography]. Presse Med 2009, 38:11-19.
37. Assie C., Janvresse A., Plissonnier D., Levesque H., Marie I. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36patients. Medicine (Baltimore) 2011, 90:40-51.
38. Ma-Krupa W., Jeon M.S., Spoerl S., Tedder T.F., Goronzy J.J., Weyand C.M. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004, 199:173-183.
39. Kaiser M., Weyand C.M., Björnsson J., Goronzy J.J. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998, 41:623-633.
40. Weyand C.M., Schönberger J., Oppitz U., Hunder N.N., Hicok K.C., Goronzy J.J. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994, 179:951-960.
41. Weyand C.M., Tetzlaff N., Björnsson J., Brack A., Younge B., Goronzy J.J. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997, 40:19-26.
42. Rodríguez-Pla A., Bosch-Gil J.A., Rosselló-Urgell J., Huguet-Redecilla P., Stone J.H., Vilardell-Tarres M. Metalloproteinase-2and -9in giant cell arteritis: involvement in vascular remodeling. Circulation 2005, 112:264-269.
43. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994, 75:539-545.
44. Deng J., Younge B.R., Olshen R.A., Goronzy J.J., Weyand C.M. Th17and Th1T-cell responses in giant cell arteritis. Circulation 2010, 121:906-915.
45. Piggott K., Deng J., Warrington K., Younge B., Kubo J.T., Desai M., et al. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation 2011, 123:309-318.
46. Oz M.C., Brener B.J., Buda J.A., Todd G., Brenner R.W., Goldenkranz R.J., et al. A ten-year experience with bacterial aortitis. J Vasc Surg 1989, 10:439-449.
47. Gonzalez-Gay M.A. Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001, 3:154-157.
48. Brack A., Martinez-Taboada V., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-317.
49. Hoffman G.S. Large-vessel vasculitis: unresolved issues. Arthritis Rheum 2003, 48:2406-2414.
50. Okuyama K., Yaginuma G., Takahashi T., Sasaki H., Mori S. The development of vasa vasorum of the human aorta in various conditions. A morphometric study. Arch Pathol Lab Med 1988, 112:721-725.
51. Fischer G.M., Swain M.L., Cherian K. Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit. Variation in synthesis among major vessels. Atherosclerosis 1980, 35:11-20.
52. Duhaut P., Pinede L., Demolombe-Rague S., Loire R., Seydoux D., Ninet J., et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Arthritis Rheum 1998, 41:1960-1965.
53. Hervé F., Choussy V., Janvresse A., Cailleux N., Levesque H., Marie I. [Aortic involvement in giant cell arteritis. A prospective follow-up of 11patients using computed tomography]. Rev Med Interne 2006, 27:196-202.
54. Hayreh S.S., Podhajsky P.A., Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998, 125:509-520.
55. Le Tourneau T., Millaire A., Asseman P., De Groote P., Théry C., Ducloux G. [Aortitis in Horton disease. Review of the literature]. Ann Med Interne (Paris) 1996, 147:361-368.
56. Zehr K.J., Mathur A., Orszulak T.A., Mullany C.J., Schaff H.V. Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg 2005, 79:1512-1517.
57. Schmidt W.A., Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
58. Duhaut P., Pinède L., Bornet H., Demolombe-Ragué S., Dumontet C., Ninet J., et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 1999, 58:335-341.
59. Evans J., Hunder G.G. The implications of recognizing large-vessel involvement in elderly patients with giant cell arteritis. Curr Opin Rheumatol 1997, 9:37-40.
60. García-Martínez A., Hernández-Rodríguez J., Arguis P., Paredes P., Segarra M., Lozano E., et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008, 59:422-430.
61. Blockmans D., Coudyzer W., Vanderschueren S., Stroobants S., Loeckx D., Heye S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008, 47:1179-1184.
62. Richardson M.P., Lever A.M., Fink A.M., Dixon A.K., Hazleman B.L. Survival after aortic dissection in giant cell arteritis. Ann Rheum Dis 1996, 55:332-333.
63. Penin F., Schmidt J.M., Froment J., Cuny G. [Aortic dissection and Horton's disease. 2cases]. Ann Med Interne (Paris) 1984, 135:153-157.
64. Salisbury R.S., Hazleman B.L. Successful treatment of dissecting aortic aneurysm due to giant cell arteritis. Ann Rheum Dis 1981, 40:507-508.
65. Kay R.H., Pooley R., Herman M.V. Unsuspected giant cell arteritis diagnosed at open heart surgery. Arch Intern Med 1982, 142:1378-1379.
66. Mitnick H.J., Tunick P.A., Rotterdam H., Esposito R. Antemortem diagnosis of giant cell aortitis. J Rheumatol 1990, 1:708-711.
67. Keenan D.J., Kieso H.A., Johnson A.M., Ross J.K. Acquired aorto-pulmonary fistula-case report. Thorac Cardiovasc Surg 1984, 32:190-192.
68. Lagrand W.K., Hoogendoorn M., Bakker K., Te Velde J., Labrie A. Aortoduodenal fistula as an unusual and fatal manifestation of giant-cell arteritis. Eur J Vasc Endovasc Surg 1996, 11:502-503.
69. Bosson C., Hadrami J., Kharsa G., Lim D.Q., Nitel M., Chotard Y. [Spontaneous rupture of the ascending aorta disclosing inflammatory arteritis]. Arch Mal Coeur Vaiss 1996, 89:1683-1686.
70. Espitia O., Néel A., Leux C., Connault J., Espitia-Thibault A., Ponge T., et al. Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22patients with longterm followup. J Rheumatol 2012, 39:2157-2162.
71. Pipitone N., Boiardi L., Bajocchi G., Salvarani C. Long-term outcome of giant cell arteritis. Clin Exp Rheumatol 2006, 24:S65-S70.
72. Stanson A.W. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000, 18:S43-S48.
73. Stanson A.W., Klein R.G., Hunder G.G. Extracranial angiographic findings in giant cell (temporal) arteritis. AJR Am J Roentgenol 1976, 12:957-963.
74. García Vázquez J.M., Carreira J.M., Seoane C., Vidal J.J. Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up. Clin Rheumatol 1999, 18:61-65.
75. Both M., Aries P.M., Müller-Hülsbeck S., Jahnke T., Schäfer P.J., Gross W.L., et al. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis 2006, 65:1124-1130.
76. Agard C., Hamidou M.A., Said L., Ponge T., Connault J., Chevalet P., et al. [Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis. A prospective study of 30patients]. Rev Med Interne 2007, 28:363-370.
77. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
78. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011, 38:1764-1772.
79. Liozon E., Monteil J., Ly K.H., Vidal E. [Vasculitis assessment with [18F]FDG positron emission tomography]. Rev Med Interne 2010, 31:417-427.
80. Pipitone N., Versari A., Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 2008, 47:403-408.
81. Walter M.A. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am 2007, 45:735-744.
82. Derdelinckx I., Maes A., Bogaert J., Mortelmans L., Blockmans D. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol 2000, 55:193-195.
83. Walter M.A., Melzer R.A., Schindler C., Müller-Brand J., Tyndall A., Nitzsche E.U. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005, 32:674-681.
84. Blockmans D., De Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35patients. Arthritis Rheum 2006, 55:131-137.
85. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C.O., Lehmann K., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
86. Henes J.C., Müller M., Krieger J., Balletshofer B., Pfannenberg A.C., Kanz L., et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2008, 26:S47-S52.
87. De Leeuw K., Bijl M., Jager P.L. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 2004, 22:S21-S26.
88. Cimmino M.A., Zampogna G., Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?. Rheumatology (Oxford) 2008, 47:926-927.
89. Hautzel H., Sander O., Heinzel A., Schneider M., Müller H.W. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 2008, 49:1107-1113.
90. Blockmans D. The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 2003, 21:S15-S22.
91. Seo P., Stone J.H. Large-vessel vasculitis. Arthritis Rheum 2004, 51:128-139.
92. Scheel A.K., Meller J., Vosshenrich R., Kohlhoff E., Siefker U., Müller G.A., et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 2004, 63:1507-1510.
93. Belhocine T., Kaye O., Delanaye P., Corman V., Baghaie M., Deprez M., et al. [Horton's disease and extra-temporal vessel locations: role of 18FDG PET scan Report of 3cases and review of the literature]. Rev Med Interne 2002, 23:584-591.
94. Brodmann M., Passath A., Aigner R., Seinost G., Stark G., Pilger E. F18-FDG-PET as a helpful tool in the diagnosis of giant cell arteritis. Rheumatology (Oxford) 2003, 42:1264-1266.
95. Desai M.Y., Stone J.H., Foo T.K.F., Hellmann D.B., Lima J.A.C., Bluemke D.A. Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. AJR Am J Roentgenol 2005, 184:1427-1431.
96. Andrews J., Mason J.C. Takayasu's arteritis-recent advances in imaging offer promise. Rheumatology (Oxford) 2007, 46:6-15.
97. Tso E., Flamm S.D., White R.D., Schvartzman P.R., Mascha E., Hoffman G.S. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002, 46:1634-1642.
98. Both M., Ahmadi-Simab K., Reuter M., Dourvos O., Fritzer E., Ullrich S., et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008, 67:1030-1033.
99. Détaint D. Prise en charge thérapeutique des anévrismes de l'aorte ascendante. AMC Pratique 2010, 185:15-21.
100. Bongartz T., Matteson E.L. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006, 18:10-17.
101. Agard C., Barrier J.H. [Complicated Horton's syndrome: therapeutic modalities]. Presse Med 2004, 33:51-59.
102. Beyer C., Axmann R., Sahinbegovic E., Distler J.H., Manger B., Schett G., et al. Anti-interleukin 6receptor therapy as rescue treatment for giant cell arteritis. Ann Rheum Dis 2011, 70:1874-1875.
103. Ray J.G., Mamdani M.M., Geerts W.H. Giant cell arteritis and cardiovascular disease in older adults. Heart 2005, 91:324-328.
104. Gonzalez-Gay M.A., Piñeiro A., Gomez-Gigirey A., Garcia-Porrua C., Pego-Reigosa R., Dierssen-Sotos T., et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004, 83:342-347.
105. Shores J., Berger K.R., Murphy E.A., Pyeritz R.E. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994, 330:1335-1341.
106. Gadowski G.R., Pilcher D.B., Ricci M.A. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994, 19:727-731.